The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans
Open accessAbstract
In this study, we examined the importance of membrane ergosterol and sphingolipids in the drug susceptibilities of Candida albicans . We used three independent methods to test the drug susceptibilities of erg mutant cells, which were defective in ergosterol biosynthesis. While spot and filter disk assays revealed that erg2 and erg16 mutant cells of C. albicans became hypersensitive to almost all of the drugs tested (i.e., 4-nitroquinoline oxide, terbinafine, o -phenanthroline, itraconazole, and ketoconazole), determination of the MIC at which 80% of the cells were inhibited revealed more than fourfold increase in susceptibility to ketoconazole and terbinafine. Treatment of wild-type C. albicans cells with fumonisin B1 resulted in 45% inhibition of sphingolipid biosynthesis and caused cells to become hypersensitive to the above drugs. Although erg mutants displayed enhanced membrane fluidity and passive diffusion, these changes alone were not sufficient to elicit the observed hypersusceptibility phenotype of erg mutants. For example, the induction in vitro of a 12% change in the membrane fluidity of C. albicans cells by a membrane fluidizer, benzyl alcohol, did not affect the drug susceptibilities of Candida cells. Additionally, the surface localization of green fluorescent protein-tagged Cdr1p, a major drug efflux pump protein of C. albicans , revealed that any disruption in ergosterol and sphingolipid interactions also interfered with its proper surface localization and functioning. A 50% reduction in the efflux of the Cdr1p substrate, rhodamine 6G, in erg mutant cells or in cells with a reduced sphingolipid content suggested a strong correlation between these membrane lipid components and this major efflux pump protein. Taken together, the results of our study demonstrate for the first time that there is an interaction between membrane ergosterol and sphingolipids, that a reduction in the content of either of these two components results in a disruption of this interaction, and that this disruption has deleterious effects on the drug susceptibilities of C. albicans cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By using the technology of gene disruption and controlled gene expression, ERG1 , ERG7 , ERG9 , ERG25 , ERG26 , and ERG27 have been proved to be essential, while ERG2 , ERG3 , ERG5 , ERG6 , and ERG24 are considered to be non-essential in ergosterol biosynthesis.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast
Bagnat, M., Keränen, S., Shevchenko, A., Shevchenko, A., & Simons, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3254 · Cited by 573
Xu, X., Bittman, R., Duportail, G., Heissler, D., Vilchèze, C., & London, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104776200 · Cited by 530
Resistance Mechanisms in Clinical Isolates of Candida albicans
White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461
Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3065 · Cited by 339
PHYSIOLOGICAL IMPLICATIONS OF STEROL BIOSYNTHESIS IN YEAST
Parks, L. W., & Casey, W. M. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.000523 · Cited by 336
Maxfield, F. R. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00351-4 · Cited by 296
Research works printed but not linked: 1
- Odds F. C. 1988. Candida and candidosis: a review and bibliography. Ballière Tindall London England.
Cited by
Sorted by citations
A Human-Curated Annotation of the Candida albicans Genome
Braun, B. R., van het Hoog, M., d'Enfert, C., Martchenko, M., Dungan, J., Kuo, A., Inglis, D. O., Uhl, M. A., Hogues, H., Berriman, M., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010001 · Cited by 342
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300
An update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
Antifungal Peptides as Therapeutic Agents
de Ullivarri, M. F., Arbulu, S., García-Gutiérrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 275
Antifungal peptides: To be or not to be membrane active
Rautenbach, M., Troskie, A. M., & Vosloo, J. A. (2016) · Biochimie · doi:10.1016/j.biochi.2016.05.013 · Cited by 213
Multidrug Resistance in Yeast Candida
Prasad, R., & Kapoor, K. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42005-1 · Cited by 182
Self-citationRadhakrishnan, V. S., Mudiam, M. K. R., Kumar, M., Dwivedi, S. P., Singh, S. P., & Prasad, T. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s150648 · Cited by 184
Self-citationRole for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms
Perumal, P., Mekala, S., & Chaffin, W. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01237-06 · Cited by 165
Becher, R., Hettwer, U., Karlovský, P., Deising, H. B., & Wirsel, S. G. R. (2010) · Phytopathology · doi:10.1094/phyto-100-5-0444 · Cited by 150
Prasad, T., Chandra, A., Mukhopadhyay, C. K., & Prasad, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00653-06 · Cited by 149
Self-citationInfluence of cholesterol and ergosterol on membrane dynamics: a fluorescence approach
Arora, A., Raghuraman, H., & Chattopadhyay, A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.118 · Cited by 135
Self-citationLv, Q.-Z., Yan, L., & Jiang, Y.-Y. (2016) · Virulence · doi:10.1080/21505594.2016.1188236 · Cited by 133
Candida albicans gains azole resistance by altering sphingolipid composition
Gao, J., Wang, H., Li, Z., Wong, A. H.-H., Wang, Y.-Z., Guo, Y., Lin, X., Zeng, G., Liu, H., Wang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06944-1 · Cited by 130
Mulhern, S. M., Logue, M. E., & Butler, G. (2006) · Eukaryotic Cell · doi:10.1128/ec.00155-06 · Cited by 130
Pasrija, R., Panwar, S. L., & Prasad, R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00861-07 · Cited by 125
Self-citationGenome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon
Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhäuser, J., Nantel, A., Raymond, M., & Rogers, P. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00327-07 · Cited by 123
MFS transportome of the human pathogenic yeast Candida albicans
Gaur, M., Puri, N., Manoharlal, R., Rai, V., Mukhopadhayay, G., Choudhury, D., & Prasad, R. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-579 · Cited by 110
Self-citationThomas, E., Roman, E., Claypool, S., Manzoor, N., Pla, J., & Panwar, S. L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00889-13 · Cited by 105
Wei, J., Bi, Y., Xue, H., Wang, Y., Zong, Y., & Prusky, D. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14601 · Cited by 102
Elucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 103
Multi-omics Signature of Candida auris , an Emerging and Multidrug-Resistant Pathogen
Zamith-Miranda, D., Heyman, H. M., Cleare, L. G., Couvillion, S. P., Clair, G. C., Bredeweg, E. L., Gacser, A., Nimrichter, L., Nakayasu, E. S., & Nosanchuk, J. D. (2019) · mSystems · doi:10.1128/msystems.00257-19 · Cited by 99
Candida auris : multi-omics signature of an emerging and multidrug-resistant pathogen
Zamith-Miranda, D., Heyman, H. M., Cleare, L. G., Couvillion, S., Clair, G., Bredeweg, E., Gacser, A., Nimrichter, L., Nakayasu, E. S., & Nosanchuk, J. D. (2019) · doi:10.1101/528232 · Cited by 99
Pasrija, R., Banerjee, D., & Prasad, R. (2007) · Eukaryotic Cell · doi:10.1128/ec.00315-06 · Cited by 91
Self-citationMir, I. A., Radhakrishanan, V. S., Rawat, K., Prasad, T., & Bohidar, H. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-27246-y · Cited by 88
Self-citationSellam, A., DONGO, A., Guillemette, T., Hudhomme, P., & Simoneau, P. (2007) · Molecular Plant Pathology · doi:10.1111/j.1364-3703.2007.00387.x · Cited by 83
Prasad, T., Saini, P., Gaur, N. A., Vishwakarma, R. A., Khan, L. A., Haq, Q. M. R., & Prasad, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3442-3452.2005 · Cited by 83
Self-citationYeast metabolic engineering – Targeting sterol metabolism and terpenoid formation
Wriessnegger, T., & Pichler, H. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.03.001 · Cited by 85
Candida albicans targets that potentially synergize with fluconazole
Lu, H., Shrivastava, M., Whiteway, M., & Jiang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1884641 · Cited by 81
Johnston, E. J., Moses, T., & Rosser, S. J. (2020) · Yeast · doi:10.1002/yea.3452 · Cited by 74
Singh, A., Yadav, V., & Prasad, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039812 · Cited by 72
Self-citationPrasath, K. G., Sethupathy, S., & Pandian, S. K. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103503 · Cited by 78
Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans
Tafesse, F., Rashidfarrokhi, A., Schmidt, F. I., Freinkman, E., Dougan, S. K., Dougan, M. L., Esteban, A., Maruyama, T., Strijbis, K., & Ploegh, H. L. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005188 · Cited by 71
Hameed, S., Dhamgaye, S., Singh, A., Goswami, S. K., & Prasad, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018684 · Cited by 69
Self-citationSphingolipid Biosynthetic Pathway Genes FEN1 and SUR4 Modulate Amphotericin B Resistance
Sharma, S., Alfatah, Bari, V. K., Rawal, Y., Paul, S. K., & Ganesan, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02130-13 · Cited by 68
Priyadarshini, E., Rawat, K., Prasad, T., & Bohidar, H. B. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.01.006 · Cited by 65
Self-citationErgosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63
Khandelwal, N. K., Chauhan, N., Sarkar, P., Esquivel, B. D., Coccetti, P., Singh, A., Coste, A. T., Gupta, M., Sanglard, D., White, T. C., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807032 · Cited by 59
Self-citationJia, D., & Sun, W. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104937 · Cited by 58
Radhakrishnan, V. S., Dwivedi, S. P., Siddiqui, M. H., & Prasad, T. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s125010 · Cited by 55
Self-citationPadovan, A. C. B., Rocha, W. P. D. S., Toti, A. C. D. M., de Jesus, D. F. F., Chaves, G. M., & Colombo, A. L. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103267 · Cited by 55
Phospholipidome of Candida : Each Species of Candida Has Distinctive Phospholipid Molecular Species
Singh, A., Prasad, T., Kapoor, K., Mandal, A., Roth, M. R., Welti, R., & Prasad, R. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0041 · Cited by 54
Self-citationPasrija, R., Krishnamurthy, S., Prasad, T., Ernst, J. F., & Prasad, R. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki112 · Cited by 53
Self-citationMo, C., & Bard, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.11.002 · Cited by 53
Hameed, S., Prasad, T., Banerjee, D., Chandra, A., Mukhopadhyay, C. K., Goswami, S. K., Lattif, A. A., Chandra, J., Mukherjee, P. K., Ghannoum, M. A., et al. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2008.00394.x · Cited by 52
Self-citationSingh, A., & Prasad, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019266 · Cited by 51
Self-citationFluconazole resistance in Candida albicans is induced by Pseudomonas aeruginosa quorum sensing
Bandara, N., Wood, D., Vanwonterghem, I., Hugenholtz, P., Cheung, B. P. K., & Samaranayake, L. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-64761-3 · Cited by 54
Membrane raft lipid constituents affect drug susceptibilities of Candida albicans
Prasad, T., Pasrija, R., & Prasad, R. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051219 · Cited by 51
Self-citationRevie, N. M., Iyer, K. R., Maxson, M. E., Zhang, J., Yan, S., Fernandes, C. M., Meyer, K. J., Chen, X., Skulska, I., Fogal, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31308-1 · Cited by 48
Lee, H., Lamichhane, A. K., Garraffo, H. M., Kwon-Chung, K. J., & Chang, Y. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08016.x · Cited by 50
Shrivastava, S. K., & Chattopadhyay, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.032 · Cited by 46
Self-citationJia, X. M., Wang, Y., Jia, Y., Gao, P. H., Xu, Y. G., Wang, L., Cao, Y. Y., Cao, Y. B., Zhang, L. X., & Jiang, Y. Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8409-3 · Cited by 45
Lipids of Candida albicans and their role in multidrug resistance
Prasad, R., & Singh, A. (2013) · Current Genetics · doi:10.1007/s00294-013-0402-1 · Cited by 45
Self-citationBanerjee, D., Lelandais, G., Shukla, S., Mukhopadhyay, G., Jacq, C., Devaux, F., & Prasad, R. (2007) · Eukaryotic Cell · doi:10.1128/ec.00256-07 · Cited by 44
Self-citationA functional link between hyphal maintenance and quorum sensing in Candida albicans
Polke, M., Sprenger, M., Scherlach, K., Albán‐Proaño, M. C., Martin, R., Hertweck, C., Hube, B., & Jacobsen, I. D. (2016) · Molecular Microbiology · doi:10.1111/mmi.13526 · Cited by 46
Interactions of Phenothiazines with Lipid Bilayer and their Role in Multidrug Resistance Reversal
Michalak, K., Wesołowska, O., Motohashi, N., Molnár, J., & Hendrich, A. B. (2006) · Current Drug Targets · doi:10.2174/138945006778226570 · Cited by 43
Cavalheiro, M., Costa, C., Silva-Dias, A., Miranda, I. M., Wang, C., Pais, P., Pinto, S. N., Mil-Homens, D., Sato-Okamoto, M., Takahashi-Nakaguchi, A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00995-18 · Cited by 42
Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p
Ferreira, C., Silva, S. M., Faria‐Oliveira, F., Pinho, E., Henriques, M., & Lucas, C. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-238 · Cited by 43
Sphingolipids: Regulators of azole drug resistance and fungal pathogenicity
Song, J., Xiao, L., & Li, R. (2020) · Molecular Microbiology · doi:10.1111/mmi.14586 · Cited by 38
Membrane raft lipid constituents affect drug susceptibilities of Candida albicans
Pasrija, R., Prasad, T., & Prasad, R. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331219 · Cited by 37
Self-citationDhamgaye, S., Devaux, F., Manoharlal, R., Vandeputte, P., Shah, A. H., Singh, A., Blugeon, C., Sanglard, D., & Prasad, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-11 · Cited by 35
Self-citationSantra, R. C., Sengupta, K., Dey, R., Shireen, T., Das, P., Guin, P. S., Mukhopadhyay, K., & Das, S. K. (2014) · Journal of Coordination Chemistry · doi:10.1080/00958972.2013.879647 · Cited by 35
Self-citationBlocking and dislocation of Candida albicans Cdr1p transporter by styrylquinolines
Szczepaniak, J., Cieślik, W., Romanowicz, A., Musioł, R., & Krasowska, A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.044 · Cited by 35
Khandelwal, N., Sarkar, P., Gaur, N. A., Chattopadhyay, A., & Prasad, R. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.05.016 · Cited by 35
Self-citationZhang, J., Yu, X., Zhang, C., Zhang, Q., Sun, Y., Zhu, H., & Tang, C. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124029 · Cited by 34
Pucadyil, T. J., & Chattopadhyay, A. (2006) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2006.04.003 · Cited by 33
Self-citationSynergistic mechanisms of retigeric acid B and azoles against Candida albicans
Sun, L., Cheng, A., Wu, X. Z., Zhang, H. J., & Lou, H. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04429.x · Cited by 32
Ren, B., Dai, H., Pei, G., Tong, Y., Zhuo, Y., Yang, N., Su, M.-Y., Huang, P., Yang, Y., & Zhang, L. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5425-5 · Cited by 31
Pais, P., Califórnia, R., Galocha, M., Viana, R., Ola, M., Cavalheiro, M., Takahashi‐Nakaguchi, A., Chibana, H., Butler, G., & Teixeira, M. C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00554-20 · Cited by 36
Lipidomics and in Vitro Azole Resistance in Candida albicans
Singh, A., Mahto, K. K., & Prasad, R. (2013) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2012.0075 · Cited by 31
Self-citationGuo, H., Xie, S. M., Li, S. X., Song, Y. J., Lv, X. L., & Zhang, H. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.073890-0 · Cited by 30
Sphingolipids and membrane biology as determined from genetic models
Rao, R. P., & Acharya, J. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.10.002 · Cited by 30
Antifungal membranolytic activity of the tyrocidines against filamentous plant fungi
Rautenbach, M., Troskie, A. M., Vosloo, J. A., & Dathe, M. (2016) · Biochimie · doi:10.1016/j.biochi.2016.06.008 · Cited by 30
Membrane homoeostasis and multidrug resistance in yeast
Panwar, S. L., Pasrija, R., & Prasad, R. (2008) · Bioscience Reports · doi:10.1042/bsr20080071 · Cited by 29
Self-citationRecent Advances in the Use of Cyclodextrins in Antifungal Formulations
Macaev, F., Boldescu, V., Geronikaki, A. A., & Sucman, N. S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660194 · Cited by 27
Lipid metabolism inCryptococcus neoformans
Shea, J. M., Henry, J. L., & Poeta, M. D. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00080.x · Cited by 27
Ferreira, C., & Lucas, C. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.011 · Cited by 27
Urbanek, A. K., Muraszko, J., Derkacz, D., Łukaszewicz, M., Bernat, P., & Krasowska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179975 · Cited by 26
Mishra, N. N., Prasad, T., Sharma, N., & Gupta, D. K. (2008) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822008000200004 · Cited by 25
Self-citationChong, H. S., Campbell, L. T., Padula, M. P., Hill, C. J., Harry, E. J., Li, S. S., Wilkins, M. R., Herbert, B. R., & Carter, D. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042835 · Cited by 25
Rouabhia, M., Mukherjee, P. K., Lattif, A. A., Curt, S., Chandra, J., & Ghannoum, M. A. (2010) · Medical Mycology · doi:10.3109/13693786.2010.535031 · Cited by 24
Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR inCandida albicans
Hameed, S., & Fatima, Z. (2013) · International Journal of Microbiology · doi:10.1155/2013/240209 · Cited by 24
Bastos, A. E. P., Marinho, H. S., Cordeiro, A. M., de Soure, A. M., & de Almeida, R. F. M. (2012) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2012.06.002 · Cited by 23
Preeti, P., Radhakrishnan, V. S., Mukherjee, S., Mukherjee, S., Singh, S. P., & Prasad, T. (2020) · Frontiers in Nanotechnology · doi:10.3389/fnano.2020.576342 · Cited by 23
Self-citationChand, P., Kumari, S., Mondal, N., Singh, S. P., & Prasad, T. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.624564 · Cited by 23
Self-citationAlavizargar, A., Keller, F., Wedlich‐Söldner, R., & Heuer, A. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03528 · Cited by 23
Wang, J., Yang, C., Hu, X., Yao, X., Han, L. S., Wu, X., Li, R., Wen, T., & Ming, L. (2022) · Journal of Fungi · doi:10.3390/jof8020153 · Cited by 21
Activity of Fusarium oxysporum-Based Silver Nanoparticles on Candida spp. Oral Isolates
Fonseca, M. S., Rodrigues, D. M., Sokolonski, A. R., Stanišić, D., Tomé, L. M. R., Goés‐Neto, A., Azevedo, V., Meyer, R., de Araújo, D. B., Tasić, L., et al. (2022) · Nanomaterials · doi:10.3390/nano12030501 · Cited by 23
Mathematical Modeling and Validation of the Ergosterol Pathway in Saccharomyces cerevisiae
Alvarez‐Vasquez, F., Riezman, H., Hannun, Y. A., & Voit, E. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028344 · Cited by 21
Differential dynamics of membrane proteins in yeast
Ganguly, S., Singh, P., Manoharlal, R., Prasad, R., & Chattopadhyay, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.054 · Cited by 20
Self-citationSantra, R. C., Ganguly, D., Singh, J., Mukhopadhyay, K., & Das, S. K. (2014) · Dalton Transactions · doi:10.1039/c4dt03362k · Cited by 20
Self-citationEstimation of Candida albicans ABC Transporter Behavior in Real-Time via Fluorescence
Szczepaniak, J., Łukaszewicz, M., & Krasowska, A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01382 · Cited by 20
Guan, W., Jiang, H., Guo, X., Mancera, E., Xu, L., Li, Y., Steinmetz, L. M., Li, Y., & Gu, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011309 · Cited by 19
Sun, J., Zhang, T., Li, Y., Wang, X., & Chen, J. (2018) · Biological Control · doi:10.1016/j.biocontrol.2018.10.004 · Cited by 19
Hans, S., Fatima, Z., & Hameed, S. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.003 · Cited by 20
Chand, P., Narula, K., Radhakrishnan, V. S., Sharma, S., Kumari, S., Mondal, N., Singh, S. P., Mishra, P., & Prasad, T. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00562 · Cited by 19
Self-citationAntifungal Activities and Preliminary Phytochemical Investigation of Combretum Species from Zimbabwe
Mangoyi, R., Mafukidze, W., & Marobela, K. A. (2012) · Journal of Microbial & Biochemical Technology · doi:10.4172/1948-5948.1000069 · Cited by 18
A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance
Song, N., Zhou, X., Li, D., Li, X., & Liu, W. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02105-21 · Cited by 17
Sphingolipid diversity in Candida auris: unraveling interclade and drug resistance fingerprints
Ali, B., Kumar, M., Kumar, P., Chauhan, A., Usmani, S. A., Rudramurthy, S. M., Meis, J. F. G. M., Chakrabarti, A., Singh, A., Gaur, N. A., et al. (2024) · FEMS Yeast Research · doi:10.1093/femsyr/foae008 · Cited by 17
Self-citationLicursi, V., Salvi, C., Cesare, V. D., Rinaldi, T., Mattei, B., Fabbri, C., Serino, G., Bramasole, L., Zimbler, J. Z., Pick, E., et al. (2013) · FEBS Journal · doi:10.1111/febs.12584 · Cited by 17
Sgherri, C., Porta, A., Castellano, S., Pinzino, C., Quartacci, M. F., & Calucci, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.10.015 · Cited by 16
Metadata
- Authors
- Mukhopadhyay, K., Prasad, T., Saini, P., Pucadyil, T. J., Chattopadhyay, A., & Prasad, R.
- Affiliations
- Jawaharlal Nehru University (IN)
- Centre for Cellular and Molecular Biology (IN)
- Corresponding author
- Prasad, Rajendra
- ORCID
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-05
- Volume
- 48
- Issue
- 5
- Pages
- 1778-1787
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC400589
- OpenAlex
- W2157978054
- Cited by
- 163
- References
- 47
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 13 · 2023: 8 · 2022: 12 · 2021: 6 · 2020: 9 · 2019: 10 · 2018: 11 · 2017: 6 · 2016: 6 · 2015: 2 · 2014: 7 · 2013: 10 · 2012: 7
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Council of Scientific and Industrial Research, India
- International Centre for Genetic Engineering and Biotechnology
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- Candida albicans, multidrug resistance, ergosterol, sphingolipids, membrane lipid interactions, ERG2, fumonisin B1, drug sensitivity, Cdr1p, drug efflux pumps, membrane fluidity, terbinafine, ketoconazole, itraconazole, 1,10-phenanthroline
- MeSH terms
- Antifungal Agents, Candida albicans, Culture Media, Ergosterol, Fungal Proteins, Luminescent Proteins, Membrane Lipids, Microbial Sensitivity Tests, Microscopy, Fluorescence, Spheroplasts, Sphingolipids, Fluorescence Polarization Immunoassay, Microscopy, Confocal, Drug Resistance, Multiple, Fungal, Membrane Transport Proteins, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review